Short answer
SUPERNUS PHARMACEUTICALS, INC. (SUPN) filed an 8-K current report with the SEC on February 24, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 or full-year 2025 earnings results reported; filing signed February 24, 2026 by CFO Timothy C. Dec.
SUPERNUS PHARMACEUTICALS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 or full-year 2025 earnings results reported; filing signed February 24, 2026 by CFO Timothy C. Dec
- Actual financial figures contained in referenced exhibit: investor should review attached press release for revenue, EPS, and guidance details
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SUPERNUS PHARMACEUTICALS, INC. 8-K filings
Get the next SUPN 8-K as it lands
Follow SUPN for push alerts, or ask the research agent what this filing means.